EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating the Effects of a New Peptide, Derived from the Enterolobium contortisiliquum Proteinase Inhibitor (EcTI), on Inflammation, Remodeling, and Oxidative Stress in an Experimental Mouse Model of Asthma–Chronic Obstructive Pulmonary Disease Overlap (ACO)

Jéssica Anastácia Silva Barbosa iD, Luana Laura Sales da Silva iD, Juliana Morelli Lopes Gonçalves João, Elaine Cristina de Campos, Silvia Fukuzaki, Leandro do Nascimento Camargo, Tabata Maruyama Dos Santos, Henrique Tibucheski Dos Santos, Suellen Karoline Moreira Bezerra, Beatriz Mangueira Saraiva-Romanholo, Fernanda Degobbi Tenório Quirino Dos Santos Lopes iD, Camila Ramalho Bonturi iD und 4 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241914710 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Jéssica Anastácia Silva Barbosa und 15 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo 01246-903, Brazil. Hauptthemen laut MEDLINE: Asthma, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation, Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Laboratory of Medical Investigations.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The synthesized peptide derived from Enterolobium contortisiliquum (pep3-EcTI) has been associated with potent anti-inflammatory and antioxidant effects, and it may be a potential new treatment for asthma–COPD overlap—ACO). Purpose: To investigate the primary sequence effects of pep3-EcTI in an experimental ACO. BALB/c mice were divided into eight groups: SAL (saline), OVA (ovalbumin), ELA (elastase), ACO (ovalbumin + elastase), ACO-pep3-EcTI (treated with inhibitor), ACO-DX (treated with dexamethasone), ACO-DX-pep3-EcTI (treated with dexamethasone and inhibitor), and SAL-pep3-EcTI (saline group treated with inhibitor). We evaluated the hyperresponsiveness to methacholine, exhaled nitric oxide, bronchoalveolar lavage fluid (BALF), mean linear intercept (Lm), inflammatory markers, tumor necrosis factor (TNF-α), interferon (IFN)), matrix metalloproteinases (MMPs), growth factor (TGF-β), collagen fibers, the oxidative stress marker inducible nitric oxide synthase (iNOS), transcription factors, and the signaling pathway NF-κB in the airways (AW) and alveolar septa (AS). Statistical analysis was conducted using one-way ANOVA and t-tests, significant when p < 0.05. ACO caused alterations in the airways and alveolar septa. Compared with SAL, ACO-pep3-EcTI reversed the changes in the percentage of resistance of the respiratory system (%Rrs), the elastance of the respiratory system (%Ers), tissue resistance (%Gtis), tissue elastance (%Htis), airway resistance (%Raw), Lm, exhaled nitric oxide (ENO), lymphocytes, IL-4, IL-5, IL-6, IL-10, IL-13, IL-17, TNF-α, INF-γ, MMP-12, transforming growth factor (TGF)-β, collagen fibers, and iNOS. ACO-DX reversed the changes in %Rrs, %Ers, %Gtis, %Htis, %Raw, total cells, eosinophils, neutrophils, lymphocytes, macrophages, IL-1β, IL-6, IL-10, IL-13, IL-17, TNF-α, INF-γ, MMP-12, TGF-β, collagen fibers, and iNOS. ACO-DX-pep3-EcTI reversed the changes, as was also observed for the pep3-EcTI and the ACO-DX-pep3-EcTI. Significance: The pep3-EcTI was revealed to be a promising strategy for the treatment of ACO, asthma, and COPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaPulmonary Disease, Chronic ObstructiveAnimalsMiceInterleukin-10Interleukin-17OvalbuminInterleukin-13Tumor Necrosis Factor-alphaNitric OxideInterleukin-6Matrix Metalloproteinase 12LungInflammationProtease InhibitorsBronchoalveolar Lavage FluidOxidative StressCollagenPancreatic ElastaseTransforming Growth Factor betaDexamethasoneMice, Inbred BALB C

Stichwörter der Autor:innen

airway remodelingasthma–chronic obstructive pulmonary disease overlapinflammationoxidative stressprotease inhibitors

Substanzen

Interleukin-10Interleukin-17OvalbuminInterleukin-13Tumor Necrosis Factor-alphaNitric OxideInterleukin-6Matrix Metalloproteinase 12Protease InhibitorsCollagen

Autor:innen und Institutionen

  • Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo 01246-903, Brazil.
  • Hospital Sírio Libanês, São Paulo 01308-050, Brazil.
  • Department of Medicine, University City of São Paulo, São Paulo 03071-000, Brazil.
  • Departamento de Bioquímica, Universidade Federal de São Paulo (UNIFESP), São Paulo 04039-002, Brazil.

ORCID-Profile: Jéssica Anastácia Silva Barbosa, Luana Laura Sales da Silva, Fernanda Degobbi Tenório Quirino Dos Santos Lopes, Camila Ramalho Bonturi, Maria Luiza Vilela Oliva, Renato Fraga Righetti

Förderung

  • São Paulo Research Foundation
  • Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
  • Laboratory of Medical Investigations

Zitieren

APA

Barbosa, J. A. S., da Silva, L. L. S., João, J. M. L. G., de Campos, E. C., Fukuzaki, S., Camargo, L. D. N., Dos Santos, T. M., Dos Santos, H. T., Bezerra, S. K. M., Saraiva-Romanholo, B. M., Lopes, F. D. T. Q. D. S., Bonturi, C. R., Oliva, M. L. V., Leick, E. A., Righetti, R. F., & Tibério, I. F. L. C. (2023). Investigating the Effects of a New Peptide, Derived from the Enterolobium contortisiliquum Proteinase Inhibitor (EcTI), on Inflammation, Remodeling, and Oxidative Stress in an Experimental Mouse Model of Asthma–Chronic Obstructive Pulmonary Disease Overlap (ACO). International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241914710

Vancouver

Barbosa JAS, da Silva LLS, João JMLG, de Campos EC, Fukuzaki S, Camargo LDN, et al. Investigating the Effects of a New Peptide, Derived from the Enterolobium contortisiliquum Proteinase Inhibitor (EcTI), on Inflammation, Remodeling, and Oxidative Stress in an Experimental Mouse Model of Asthma–Chronic Obstructive Pulmonary Disease Overlap (ACO). International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241914710

BibTeX
@article{Barbosa2023,
  author = {Barbosa, Jéssica Anastácia Silva and da Silva, Luana Laura Sales and João, Juliana Morelli Lopes Gonçalves and de Campos, Elaine Cristina and Fukuzaki, Silvia and Camargo, Leandro do Nascimento and Dos Santos, Tabata Maruyama and Dos Santos, Henrique Tibucheski and Bezerra, Suellen Karoline Moreira and Saraiva-Romanholo, Beatriz Mangueira and Lopes, Fernanda Degobbi Tenório Quirino Dos Santos and Bonturi, Camila Ramalho and Oliva, Maria Luiza Vilela and Leick, Edna Aparecida and Righetti, Renato Fraga and Tibério, Iolanda de Fátima Lopes Calvo},
  title = {Investigating the Effects of a New Peptide, Derived from the Enterolobium contortisiliquum Proteinase Inhibitor (EcTI), on Inflammation, Remodeling, and Oxidative Stress in an Experimental Mouse Model of Asthma–Chronic Obstructive Pulmonary Disease Overlap (ACO)},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241914710}
}
Kostenlos starten →